Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Peng ChenFen YangWenya WangXiao LiDongling LiuYongxi ZhangGuotian YinFenghua LvZhikun GuoJawahar Lal MehtaXianwei WangPublished in: Journal of cardiovascular pharmacology and therapeutics (2020)
Liraglutide reduces myocardial fibrosis in the hypertensive mice, which appears to be dependent on at least in part inhibition of ROS production.